IPA ImmunoPrecise Antibodies Ltd.: Earnings per share for the trailing year

Public company logo of ImmunoPrecise (IPA)

ImmunoPrecise Antibodies (IPA) is minimizing dependency risks by outsourcing cloud hosting to external providers while retaining its proprietary algorithms. The current annual EPS TTM growth rate confirms this strategy, with the parameter value standing at 43.70. Business efficiency is bolstered by an AI platform that accelerates the development of cancer antibodies, as well as an academic culture that attracts top geneticists through stock options and R&D autonomy.

ImmunoPrecise Antibodies Ltd. (IPA): Net earnings per share (EPS TTM) from 02/11/2024 to 02/20/2024

IPA (ImmunoPrecise Antibodies Ltd): analytical breakdowns and indicator data

- stock quotes and analyst forecast:
Quote Chart ImmunoPrecise Antibodies Ltd.|IPA - Price Target Chart
- company stock capitalization data:
Market Value ImmunoPrecise|IPA - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share ImmunoPrecise Antibodies|IPA - Book Capitalization|Market Cap to Net Assets Ratio immunoprecise.com|IPA - Company Total Assets
- company total debt and liquidity indicators:
Total Debt to Capital Coefficient ImmunoPrecise Antibodies|IPA - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient immunoprecise.com|IPA - Company Aggregate Debts|Debts to Book Value ImmunoPrecise Antibodies|IPA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings ImmunoPrecise Antibodies|Quick Ratio immunoprecise.com
- net income and valuation ratios data:
IPA - Company Net Income|Net Profit Forecast ImmunoPrecise Antibodies|IPA - Price to Earnings Ratio|Market Cap to Future Earnings Ratio immunoprecise.com|IPA - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio ImmunoPrecise|IPA - Operating profit EBITDA|Earnings per share for the last twelve months ImmunoPrecise Antibodies|IPA - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months immunoprecise.com|IPA - Earnings growth in current year|Projected earnings per share growth rate for next year ImmunoPrecise Antibodies
- sales and revenue indicators:
IPA - Revenue and Sales Volume|Company Future Sales immunoprecise.com|IPA - P/S Multiple|Market Cap to Future Revenue Ratio ImmunoPrecise Antibodies Ltd.|IPA - Sales Growth YoY (Last Twelve Months)
Fundamental company valuation:IPA, ImmunoPrecise Antibodies
Original product of ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies (IPA) relies on a network of high-tech laboratories across the US, Canada, and the Netherlands. The operational efficiency of these assets is quantified through the trailing twelve-month (TTM) earnings per share (EPS) dynamics. This indicator measures the rate of change in net yield compared to the previous year, revealing the actual resilience of the business. A positive trend confirms the scalability of the operating model. By analyzing the EPS YoY TTM growth rate, an investor can distinguish fundamental growth from random market fluctuations.

Direct competitors

Earnings per share for the trailing year TEM (Tempus AI Inc)|QGEN (Qiagen Group) - Net earnings per share for the last 12 months|Earnings per one share for the last 12 months IONS (Ionis Pharma)|Earnings per share for the last twelve months Repligen|Earnings per share for the last twelve months RNA|Net earnings per share (EPS TTM) CRSP|Earnings per share for the last twelve months WGS (GeneDx)|Ultragenyx Pharmaceutical - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Beam Tx BEAM|Sarepta Therapeutics - Net earnings per share (EPS TTM)|Twist Bioscience (TWST) - Net earnings per share for the last 12 months|TXG: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Intellia Therapeutics Inc (NTLA)|STOK (stoketherapeutics.com) - Net earnings per share (EPS TTM)|BLFS (BioLife Corp) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Wave Life Sciences Ltd. (WVE)|Earnings per share for the last four quarters MAZE|sionnatx.com - Net earnings per share for the last 12 months|Earnings per share for the trailing year PRME|TSHA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months uniQure Corp|meiragtx.com (MGTX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months RGNX|Net earnings per share for the last 12 months SLDB|Net earnings per share (EPS TTM) Ocugen Inc|Earnings per share for the last twelve months PacBio Corp (PACB)|Net earnings per share for the last four quarters Benitec Corp|Net earnings per share (EPS TTM) DSGN (Design Therapeutics, Inc.)|Net earnings per share (EPS TTM) rocketpharma.com RCKT|4DMT - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Earnings per share for the last twelve months|Earnings per share for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Net earnings per share (EPS TTM)|proqr.com (PRQR) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months CDXS (Codexis Bio)|SGMO - Net earnings per one share for the last twelve months|Nautilus Biotechnology, Inc. - Net earnings per share for the last 12 months|Net earnings per share for the trailing year Metagenomi, Inc|Precision BioSciences - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Earnings per share for the last twelve months|Exicure Inc. - Earnings per share for the trailing year|IMNN (imunon.com) - Net earnings per share (EPS TTM)|Phio Pharmaceuticals - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Mustang Bio Corp (MBIO)|Net earnings per share (EPS TTM) TransCode (RNAZ)|Net earnings per share (EPS TTM) BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Earnings per one share for the last 12 months|BLUE - Earnings per share for the last twelve months|Earnings per share for the trailing year OMGA (Omega Therapeutics)|OMIC: Net earnings per share (EPS TTM)|RGLS (Regulus Therapeutics Inc.) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Syros Pharmaceuticals Inc.|Telesis Bio Inc. (TBIO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months traconpharma.com (TCON)|Earnings per share for the last four quarters UBX